Form 8-K - Current report:
SEC Accession No. 0001193125-24-178827
Filing Date
2024-07-15
Accepted
2024-07-15 07:10:01
Documents
16
Period of Report
2024-07-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d867904d8k.htm   iXBRL 8-K 60161
2 EX-1.1 d867904dex11.htm EX-1.1 144825
3 EX-5.1 d867904dex51.htm EX-5.1 10530
7 GRAPHIC g867904g16w89.jpg GRAPHIC 11232
  Complete submission text file 0001193125-24-178827.txt   403129

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA plse-20240715.xsd EX-101.SCH 2841
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE plse-20240715_lab.xml EX-101.LAB 17994
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE plse-20240715_pre.xml EX-101.PRE 11255
18 EXTRACTED XBRL INSTANCE DOCUMENT d867904d8k_htm.xml XML 3639
Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
PULSE BIOSCIENCES, INC. (Filer) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37744 | Film No.: 241115855
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)